Astec LifeSciences peers

Companies like Astec LifeScienceslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,295 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ASTEC
FY26
PUNJABCHEM
FY26
MOL
FY26
IPL
FY26
Peer
Average
Valuation — at last close
P/E—18.50×48.71×◆ 11.22×26.14×
P/B3.31×2.79×◆ 0.91×1.33×1.68× +98%
EV/EBITDA◆ -382.61×11.19×11.90×7.69×10.26× -3829%
Market Cap₹1,295 Cr₹1,183 Cr₹1,400 Cr₹1,344 Cr₹1,309 Cr -1%
Growth
Revenue CAGR 3Y-10.65%0.78%-5.21%◆ 6.12%0.56% -1991%
Revenue CAGR 5Y-4.18%◆ 8.71%——8.71% -148%
Net Income CAGR 3Y—◆ 1.54%-50.55%-5.78%-18.26%
Revenue YoY (latest Q)-2.31%◆ 8.68%-11.54%-8.51%-3.79% +39%
Net Income YoY (latest Q)-53.16%6.98%◆ 279.98%-34.78%84.06% -163%
Profitability
EBITDA Margin-1.01%11.47%8.12%◆ 16.41%12.00% -108%
Net Income Margin-18.05%6.21%1.32%◆ 11.33%6.29% -387%
Return on Common Equity-25.88%◆ 16.23%1.88%12.55%10.22% -353%
Return on Capital Employed-10.32%◆ 18.97%3.13%15.27%12.46% -183%
Return on Assets-8.87%7.88%0.94%◆ 9.67%6.16% -244%
Credit & Quality
Total Debt/Equity1.15×0.36×0.47×◆ 0.11×0.31× +267%
Interest Coverage-1.43×5.32×0.63×◆ 20.60×8.85× -116%
Scale — latest FY
Revenue / Total Income₹448 Cr₹1,030 Cr₹2,174 Cr₹1,057 Cr₹1,420 Cr -68%
Net Income−₹80.9 Cr₹64 Cr₹28.7 Cr₹120 Cr₹70.8 Cr -214%
Total Assets₹942 Cr₹823 Cr₹3,021 Cr₹1,337 Cr₹1,727 Cr -45%
EPS₹-37.79₹52.17₹1.13₹10.4₹21.23 -278%
Book Value per Share₹175.3₹345.41₹60.74₹87.67₹164.61 +6%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.